This inventor holds 4 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1991-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1998
Title: Naoki Kai: Innovator in Medicinal Chemistry
Introduction
Naoki Kai is a prominent inventor based in Amagasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating cerebral insufficiency diseases. With a total of 4 patents to his name, his work continues to impact the pharmaceutical industry.
Latest Patents
Among his latest patents, Naoki Kai has developed innovative compounds such as omega-(3,4-dihydro-2-naphthalenyl)alkyl-cyclic amine derivatives. These compounds serve as medicaments for treating cerebral insufficiency diseases. His research includes a novel medicament that comprises an active ingredient with a specific chemical formula, which has shown promise in improving cerebral function. Additionally, he has worked on 2-(1-piperazinyl)-4-phenyl-cycloalkanopyrimidine derivatives that exhibit excellent cerebral function improving activity.
Career Highlights
Naoki Kai is associated with Dainippon Pharmaceutical Company, Limited, where he has been instrumental in advancing research and development in medicinal products. His expertise in the field has led to the creation of several important patents that address critical health issues.
Collaborations
Throughout his career, Naoki has collaborated with notable colleagues, including Katsuhiko Hino and Masato Sakamoto. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Naoki Kai's contributions to medicinal chemistry and his innovative patents highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for advancements in treatments for cerebral insufficiency diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
